Safety and Tolerability of Tumor Necrosis Factor-[alpha] Inhibitors in Psoriasis: A Narrative Review

• Published in: American journal of clinical dermatology Vol. 15; no. 1; p. 37
• Main Authors: Semble, Ashley L, Davis, Scott A, Feldman, Steven R
• Format: Journal Article
• Language: English
• Published: Auckland Springer Nature B.V 01.02.2014

Tumor necrosis factor (TNF)-α inhibitors are an alternative to oral systemic therapies for psoriasis. Data regarding the safety of TNF-α inhibitors from randomized clinical trials may not fully reflect the effects on the clinic patient population receiving the therapy, but other sources of informati...